Successful treatment of metastatic testicular cancer of extreme size - Abstract

Testicular cancer is the most common cancer in young males.

Testicular cancer has one of the highest cure rates of all cancers: with modern chemotherapy treatment five-year survival rate exceeds 90 percent overall, and reaches almost 100 percent in early stages. However, these favorable results can only be achieved if these patients are transferred to a reference center, because better outcome was reported for patients who had been treated in a high volume center. Strict adherence to therapeutic protocol is vital for good results. We present a case of a testicular cancer patient with very advanced disease and poor performance status, who was deemed incurable by another oncological center. We achieved complete remission by strictly adhering to the protocol, and using all the available supportive measures. We would like to demonstrate the difficulties we were facing while treating this poor prognostic patient.

Written by:
Küronya Z, Németh H, Géczi L.   Are you the author?
C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály, Országos Onkológiai Intézet, Budapest, Hungary.  

Reference: Magy Onkol. 2014 Sep 26;58(3):225-8.


PubMed Abstract
PMID: 25260088

Article in Hungarian.

UroToday.com Testicular Cancer Section